AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+3.4%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.51B
AUM Growth
+$3.51B
(-15%)
Cap. Flow
-$436M
Cap. Flow
% of AUM
-12.4%
Top 10 Holdings %
Top 10 Hldgs %
30.68%
Holding
202
New
57
Increased
36
Reduced
24
Closed
61
Top Buys
| 1 |
Home Depot
HD
|
$105M |
| 2 |
PTC Therapeutics
PTCT
|
$79.1M |
| 3 |
Target
TGT
|
$68.3M |
| 4 |
Viatris
VTRS
|
$63.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$60.9M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$67.8M |
| 2 |
Academy Sports + Outdoors
ASO
|
$66.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$65.8M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$63.2M |
| 5 |
Ulta Beauty
ULTA
|
$62.1M |
Sector Composition
| 1 | Healthcare | 66.72% |
| 2 | Consumer Staples | 13.57% |
| 3 | Consumer Discretionary | 10.09% |
| 4 | Technology | 5.16% |
| 5 | Communication Services | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Five Below
FIVE
$8.33B
| $57.3M | 1.11% |
+361,745
| New | +$57.3M |
|
|
DCPH
27
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $54.1M | 1.05% |
5,836,000
+2,405,846
| +70% | +$22.3M |
|
28
Medtronic
MDT
$118B
| $51.9M | 1% |
468,000
-244,000
| -34% | -$27.1M |
|
29
Colgate-Palmolive
CL
$67.7B
| $48.2M | 0.93% |
636,000
+368,000
| +137% | +$27.9M |
|
30
Alkermes
ALKS
$4.95B
| $48M | 0.93% |
1,824,000
-1,348,000
| -42% | -$35.5M |
|
31
AutoZone
AZO
$70.1B
| $46M | 0.89% |
22,481
-15,543
| -41% | -$31.8M |
|
32
Walmart
WMT
$793B
| $44.8M | 0.87% |
300,894
-269,724
| -47% | -$40.2M |
|
33
Uber
UBER
$194B
| $44.1M | 0.85% |
1,236,000
+36,000
| +3% | +$1.28M |
|
34
MacroGenics
MGNX
$121M
| $44.1M | 0.85% |
5,000,000
+2,300,000
| +85% | +$20.3M |
|
35
Post Holdings
POST
$6.03B
| $44M | 0.85% |
636,000
+280,000
| +79% | +$6.37M |
|
36
Alphabet (Google) Class A
GOOGL
$2.79T
| $41.7M | 0.81% |
15,000
+3,000
| +25% | +$8.34M |
|
37
Pacira BioSciences
PCRX
$1.22B
| $40M | 0.77% |
524,000
-788,000
| -60% | -$60.1M |
|
38
AstraZeneca
AZN
$255B
| $39.3M | 0.76% |
592,000
+192,000
| +48% | +$12.7M |
|
39
Zymeworks
ZYME
$1.07B
| $37.7M | 0.73% |
5,760,000
+4,509,803
| +361% | +$29.5M |
|
40
Microsoft
MSFT
$3.76T
| $37M | 0.72% |
120,000
+22,000
| +22% | +$6.78M |
|
41
Adobe
ADBE
$148B
| $36.5M | 0.7% |
+80,000
| New | +$36.5M |
|
42
Energizer
ENR
$1.94B
| $35.3M | 0.68% |
1,148,000
-224,000
| -16% | -$6.89M |
|
43
Avalo Therapeutics
AVTX
$139M
| $34.5M | 0.67% |
47,576,000
+2,576,000
| +6% | +$1.87M |
|
|
TSVT
44
DELISTED
2seventy bio
TSVT
| $34.1M | 0.66% |
2,000,000
+1,144,000
| +134% | +$19.5M |
|
|
FMTX
45
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $29.8M | 0.58% |
3,200,000
+1,344,000
| +72% | +$12.5M |
|
46
Toast
TOST
$24.7B
| $28.8M | 0.56% |
+1,324,000
| New | +$28.8M |
|
47
Thermo Fisher Scientific
TMO
$183B
| $26.6M | 0.51% |
45,000
+21,000
| +88% | +$12.4M |
|
48
Deckers Outdoor
DECK
$18.3B
| $25.9M | 0.5% |
94,702
+39,667
| +72% | +$10.9M |
|
49
Mondelez International
MDLZ
$79.3B
| $25.1M | 0.49% |
400,000
+55,000
| +16% | +$3.45M |
|
50
Alphatec Holdings
ATEC
$2.35B
| $23.4M | 0.45% |
2,036,000
-288,000
| -12% | -$3.31M |
|